Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer: The FORCE trial

ISSN
0923-7534
Date Issued
2018
Author(s)
Bozorgmehr, F.
Hommertgen, A.
Lasitschka, F.
Krisam, J.
Debus, J.
Fischer, J.R.
Bischof, M.
Atmaca, A.
Wetzel, S.
Faehling, M.
Bottke, D.
Grohe, C.
Engel-Riedel, W.
Ingenhoff, E.
Heigener, D.F.
Reinmuth, N.
Schumann, C.
Wermke, M.
Thomas, M.
DOI
10.1093/annonc/mdy292.123